The Supreme Court has agreed to hear a case concerning the accessibility of the abortion drug mifepristone, which was initially approved by the FDA but suspended by U.S. District Judge Matthew Kacsmaryk in April 2020. The Biden administration and the maker of the drug are appealing to the Supreme Court to reverse the appellate ruling, which would impose restrictions on the drug, even in states where abortion remains legal. This is the first abortion case since the court overturned Roe v. Wade last year, and could have a significant impact on the accessibility of mifepristone and other abortion drugs.
